Evidence map›Paper›PMID 41234355›Full record

ArticleJournal of advanced pharmaceutical technology & research

Network pharmacology and molecular docking investigation of

Yusuf Alif Pratama, Honey Dzikri Marhaeny, Sulistyanengci Winarto, Igansius Agyo Palmado, Muhammad Hermawan Widyananda, Mahardian Rahmadi, Muhammad Taher, Ahmed Abdallah Hasan, Burkhard Kleuser, Junaidi Khotib

Abstract read
In one paragraph

Article in Journal of advanced pharmaceutical technology & research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yusuf Alif PratamaDoctoral Program of Pharmaceuticals Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.
Honey Dzikri MarhaenyDoctoral Program of Pharmaceuticals Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.
Sulistyanengci WinartoMaster Program of Pharmaceuticals Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.
Igansius Agyo PalmadoMaster Program of Pharmaceuticals Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.
Muhammad Hermawan WidyanandaDepartment of Biology, Faculty of Mathematics and Natural Sciences, Universitas Brawijaya, Malang, Indonesia.
Mahardian RahmadiDepartment of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.
Muhammad TaherDepartment of Pharmaceutical Technology, Kulliyyah of Pharmacy, International Islamic University Malaysia, Pahang, Malaysia.
Ahmed Abdallah HasanDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
Burkhard KleuserDepartment of Pharmacology and Toxicology, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
Junaidi KhotibDepartment of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A chronic inflammatory dermatosis, eczema, affects more than 12% of the pediatric population and 7.2% of adults. Clinically, it presents with erythematous, scaly, and intensely pruritic lesions. Severe forms of the disease frequently exhibit poor responsiveness to treatments aimed at a single inflammatory pathway.

Indexed as

Absorptionand toxicityatopic dermatitisdistributionexcretionmetabolismneglected tropical diseasenetwork analysisvirtual screening

Identifiers

PMID41234355
PMCPMC12610289

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.